search button
Open Access

Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure

  • Authors:
    • Xueliang Yang
    • Yunru Chen
    • Jian Zhang
    • Tiantian Tang
    • Ying Kong
    • Feng Ye
    • Xi Zhang
    • Xiaojing Liu
    • Shumei Lin

  • View Affiliations

  • Published online on: February 7, 2018     https://doi.org/10.3892/etm.2018.5843
  • Pages: 3231-3238

  • Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The present study aimed to evaluate whether thymosin α1 (Tα1) increases survival rates through the improvement of immunofunction and inhibition of hepatocyte apoptosis in rats with acute liver failure (ALF). A total of 25 rats were randomly divided into the control group (CG), the model group (MG) and the treatment group (TG). The CG received an intraperitoneal injection of saline (2 ml). The ALF rat model was established by the intraperitoneal injection of D‑galactosamine (700 mg/kg) and lipopolysaccharide (10 µg/kg). The TG received an intraperitoneal injection of Tα1 (0.03 mg/kg) 1 h prior to and 30 min after modeling. The survival rates of the rats were recorded. An additional 63 rats were randomly divided into a CG (n=3), MG (n=30) and TG (n=30). Three rats were sacrificed at 3, 6, 9 and 12 h after establishment of the rat model to detect plasma alanine transaminase (ALT), aspartate transaminase (AST), total bilirubin (TBIL), tumor necrosis factor (TNF)‑α and interleukin‑10 (IL‑10). Liver samples were stained with hematoxylin and eosin and TUNEL, and reverse transcription‑quantitative polymerase chain reaction and western blot analysis were performed to detect B‑cell lymphoma 2 (Bcl‑2) and Bcl‑2‑associated X protein (Bax) in liver tissue. The results indicated that the survival rate of the TG was significantly higher compared with that of the MG at 24 h (P<0.05). Plasma ALT, AST and TBIL in the MG and TG increased over time (3‑12 h), with ALT, AST and TBIL observed to be significantly lower in the TG compared with the MG at each time-point (P<0.05). Hepatocellular necrosis, hemorrhage and inflammatory cell infiltration of ALF were aggravated over time (3‑12 h) in the MG and TG. Notably, in the Tα1‑treated rats, the hepatocytes appeared healthier with fewer apoptotic cells compared with those from the MG at the same time-points. Hepatocyte apoptotic index increased in the TG and MG, but was significantly lower in the TG compared with the MG at each time-point (P<0.05) in TUNEL assays. Plasma TNF‑α and IL‑10 in the MG and TG increased over time (3‑12 h), with TNF‑α observed to be significantly lower in the TG compared with the MG at each time-point (P<0.05), however, IL‑10 was observed to be significantly higher in the TG compared with the MG at each time-point (P<0.05). Bax mRNA expression was significantly lower in the TG compared with the MG at each time-point (P<0.05), whereas Bcl‑2 was significantly higher (P<0.05). In conclusion, Tα1 improved survival rates in an ALF rat model by downregulating TNF‑α and upregulating IL‑10, leading to the attenuation of hepatic inflammation and hepatocyte apoptosis.
View Figures
View References

Related Articles

Journal Cover

April-2018
Volume 15 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.4
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Yang X, Chen Y, Zhang J, Tang T, Kong Y, Ye F, Zhang X, Liu X and Lin S: Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure. Exp Ther Med 15: 3231-3238, 2018.
APA
Yang, X., Chen, Y., Zhang, J., Tang, T., Kong, Y., Ye, F. ... Lin, S. (2018). Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure. Experimental and Therapeutic Medicine, 15, 3231-3238. https://doi.org/10.3892/etm.2018.5843
MLA
Yang, X., Chen, Y., Zhang, J., Tang, T., Kong, Y., Ye, F., Zhang, X., Liu, X., Lin, S."Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure". Experimental and Therapeutic Medicine 15.4 (2018): 3231-3238.
Chicago
Yang, X., Chen, Y., Zhang, J., Tang, T., Kong, Y., Ye, F., Zhang, X., Liu, X., Lin, S."Thymosin α1 treatment reduces hepatic inflammation and inhibits hepatocyte apoptosis in rats with acute liver failure". Experimental and Therapeutic Medicine 15, no. 4 (2018): 3231-3238. https://doi.org/10.3892/etm.2018.5843